Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III lot-to-lot consistency study of Priorix-Tetra in healthy toddlers
2004-005123-18Phase 3Completed
- Sponsor
- GSK
- Start
- Feb 2005
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of GSK208136 in measles, mumps, rubella and 1 more (3 arms), sponsored by GSK. Primary endpoint: Mumps seroconversion rate after the first dose by neutralization assay. Started Feb 2005; status: completed.
02
Drugs
GSK208136
03
Conditions
measlesmumpsrubellachickenpox
Beyond the preview
Go deeper on 2004-005123-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-005123-18.